Evidence map›Paper›PMID 31863250›Full record

ReviewJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2020

State of the art: leadless ventricular pacing : A national expert consensus of the Austrian Society of Cardiology.

C Steinwender, P Lercher, C Schukro, H Blessberger, G Prenner, M Andreas, J Kraus, M Ammer, M Stühlinger

Abstract readReviewConsensus Statement
In one paragraph

Review in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Sex-specific short- and long-term outcomes in patients with leadless cardiac pacemakers.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Observational
  5. Article
  6. Review
  7. Evolution of leadless pacemaker technology.European heart journal supplements : journal of the European Society of Cardiology · 2025
    Article
  8. Review
  9. Device Therapy in Cardiac Sarcoidosis: Current Review, Challenges, and Future Prospects.The Journal of innovations in cardiac rhythm management · 2024
    Review
  10. Chronic kidney disease and transvenous cardiac implantable electronic device infection-is there an impact on healthcare utilization, costs, disease progression, and mortality?Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  11. Article
  12. Review
  13. Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a position paper by EHRA/HRS/LAHRS/APHRS.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2022
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

C SteinwenderDepartment of Cardiology and Internal Intensive Medicine, Kepler University Hospital, Johannes Kepler University Linz, Medical Faculty, Linz, Austria.
P LercherDepartment of Cardiology, Medical University Graz, Graz, Austria.
C SchukroDepartment of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.
H BlessbergerDepartment of Cardiology and Internal Intensive Medicine, Kepler University Hospital, Johannes Kepler University Linz, Medical Faculty, Linz, Austria.
G PrennerDepartment of Cardiology, Medical University Graz, Graz, Austria.
M AndreasDepartment of Surgery, Division of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
J KrausUniversitätsklinik für Innere Medizin II, Cardiology, Paracelsus Medical University Salzburg, Salzburg, Austria.
M AmmerCardiology Department, Klinikum Wels-Grieskirchen, Wels, Austria.
M StühlingerUniversity Clinic of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Innsbruck, Austria. markus.stuehlinger@tirol-kliniken.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac pacing has been shown to improve quality of life and prognosis of patients with bradycardia for almost 60 years. The latest innovation in pacemaker therapy was miniaturization of generators to allow leadless pacing directly in the right ventricle. There is a long history and extensive experience of leadless ventricular pacing in Austria. However, no recommendations of national or international societies for indications and implantation of leadless opposed to transvenous pacing systems have been published so far.

resultsA national expert panel of skilled implanters gives an overview on the two utilized leadless cardiac pacing systems and highlights clinical advantages as well as current knowledge of performance and complication rates of leadless pacing. Furthermore, a national consensus for Austria is presented, based on recent studies and current know-how, specifically including indications for leadless pacing, management of infection, suggestions for qualification, and training of the operators and technical standards.

conclusionsLeadless pacing systems can be implanted successfully with a low complication rate, if suggestions for indications and technical requirements are followed. An overview of the two utilized leadless cardiac pacing systems is given, specifically highlighting clinical advantages as well as current knowledge of performance and complication rates. Furthermore, a national consensus for Austria is presented, specifically including indications for leadless pacing, management of infection, and suggestions for qualification and technical standards.

Indexed as

Pacemaker, ArtificialAustriaBradycardiaCardiac Pacing, ArtificialConsensusEquipment DesignHumansMiniaturizationPrognosisQuality of LifeBradycardiaCardiac implantable electronic devicesCIEDInfectionLeadless pacingPacemaker

Identifiers

PMID31863250
PMCPMC7036055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.